Anti-CD19 CAR T as a feasible therapy for refractory/relapsed mixed phenotype acute leukemia patients

Li, XQ; Chen, K; Zhang, HL; Zhang, X; Yang, JF; Liu, J; Zheng, JW; Dong, F; Zhu, YB; Yu, J; Zhang, HH; Lu, PH; Chen, B

Lu, PH (通讯作者),Lu Daopei Hosp, 6 Sipu Lang Rd, Langfang, Hebei, Peoples R China.;Chen, B (通讯作者),Kecellit Biotech Co Ltd, Beijing Econ Technol Dev Zone, 88 Kechuang 6th St, Beijing, Peoples R China.

PEDIATRIC BLOOD & CANCER, 2022; 69 (10):